Tower News

Tower Hematology Oncology Medical Group is proud to be affiliated with Cedars-Sinai, a national leader in providing high-quality, patient-centered healthcare encompassing primary care as well as specialized medicine and conducting research that leads to life-saving discoveries and innovations. Learn more…


Latest Cancer News

FDA Approves Keytruda for First-line Treatment of Head and Neck Squamous Cell Carcinoma (06-13-2019)
FDA approves Keytruda for the first-line treatment of patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC). Keytruda was approved for use in combination with... Continue Reading

FDA Approves Chemoimmunotherapy Regimen for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (06-11-2019)
The U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy Treanda (bendamustine) and Rituxan (rituximab) product (a combination... Continue Reading

More Cancer News

Locations

Tower Hematology Oncology Medical Group
9090 Wilshire Boulevard
Suite 300
Beverly Hills, CA 90211
Phone: (310) 888-8680
Click here for map